Can I Take Zinc With Adderall XR? A Clinical Review

Adderall XR is the extended-release, brand-name formulation of mixed amphetamine salts (75% dextroamphetamine, 25% levoamphetamine), a Schedule II CNS stimulant FDA-approved for ADHD and narcolepsy. Zinc is an over-the-counter mineral supplement sold as gluconate, sulfate, picolinate, citrate, and other salts.
Zinc is not listed as a drug interaction on the Adderall XR label, and there is no evidence that typical supplemental doses of zinc make Adderall XR unsafe. The two issues worth tracking are pharmacodynamic (zinc affects the same dopamine transporter that amphetamine acts on, in laboratory and animal studies) and nutritional (zinc taken above the adult Tolerable Upper Intake Level of 40 mg elemental zinc per day can deplete copper over weeks to months, per the NIH Office of Dietary Supplements). Neither concern rises to a contraindication at ordinary supplement doses, but both are reasons to tell your prescriber before starting zinc and to keep the dose bounded.
The more useful question for most readers is not "is this combination dangerous" but "what dose and timing keep the theoretical risks negligible." That is the framing this article uses.
What is established, what is plausible, and what is not established
Established: The FDA-approved label for Adderall XR does not list zinc as a drug interaction (FDA label, accessed for this review). The NIH sets an adult Tolerable Upper Intake Level for zinc at 40 mg elemental zinc per day, and chronic intake above that level is associated with copper deficiency, which can present as microcytic anemia, neutropenia, and peripheral neuropathy (NIH ODS Zinc fact sheet).
Plausible but unproven in humans on this exact combination: Laboratory and animal work has reported that zinc can modulate the dopamine transporter (DAT), the same transporter amphetamine reverses to raise synaptic dopamine. Whether this translates into a clinically noticeable reduction in Adderall XR's effect in patients taking normal supplement doses has not been established through controlled human pharmacokinetic studies. Small trials of zinc as a standalone ADHD treatment, and at least one small trial of zinc added to a stimulant, have been described in the literature, but the specific pairing of zinc with mixed amphetamine salts (rather than methylphenidate) has not been rigorously studied. Treat any specific trial numbers you see cited elsewhere (sample sizes, exact dose used, effect size) as needing verification against the original paper rather than a secondhand summary, including in earlier versions of this article.
Not established: That zinc supplementation improves or worsens Adderall XR's clinical effectiveness in a general ADHD population. That any specific zinc formulation meaningfully changes amphetamine blood levels through gastrointestinal absorption competition. That zinc supplementation is a recommended adjunct to stimulant therapy in any major pediatric or psychiatric guideline as of this writing (2025); if you find a guideline stating otherwise, verify it directly with the issuing body, since none is cited here with confidence.
What a clinician or pharmacist should verify before advising a patient: whether the patient has documented or suspected zinc deficiency, the total elemental zinc dose across all supplements and multivitamins the patient takes, whether the chosen zinc salt is one known to alkalinize urine (such as zinc citrate), and whether any baseline copper or ceruloplasmin testing is warranted given the planned dose and duration.
Evidence-status interaction assessment: zinc plus Adderall XR
| Question | Status | Basis | Action for clinician/patient |
|---|---|---|---|
| Does the FDA label flag a zinc interaction? | No signal found | Adderall XR labeling | Absence of a listed interaction is not the same as proof of safety; use clinical judgment |
| Can zinc affect the dopamine transporter amphetamine uses? | Plausible, mechanism-level | Laboratory/animal pharmacology | Do not assume clinical significance without human PK data; ask if the patient reports reduced effect after starting zinc |
| Does zinc reduce Adderall XR's clinical efficacy in humans? | Not established | No confirmed controlled human trial on this exact pairing | Do not counsel patients that zinc will blunt their medication; do not promise it will not |
| Does high-dose zinc deplete copper? | Established | NIH ODS Tolerable Upper Intake Level guidance | Cap elemental zinc near or below 40 mg/day (adult) unless a clinician is monitoring copper |
| Does zinc citrate alkalinize urine enough to extend amphetamine half-life? | Mechanistically plausible, magnitude unclear | General acid-base pharmacology of amphetamine renal clearance | If a patient reports unusually prolonged stimulant effect after switching zinc salts, note the formulation and discuss with prescriber |
| Is zinc deficiency common in ADHD populations? | Suggested by some published studies, not universally confirmed | Requires verification of the specific study before citing a number | Consider zinc testing based on diet history and symptoms, not on an assumed baseline deficiency rate |
| Do pediatric and psychiatric guidelines recommend zinc as an ADHD adjunct? | Not established in guidelines reviewed | No guideline endorsement identified | Do not present zinc as a guideline-backed adjunct therapy |
Use this table as a starting checklist, not a substitute for reviewing the primary literature or the current FDA label before making a patient-specific recommendation.
Why this combination comes up often
Zinc deficiency has been reported in some studies of children with ADHD, and Adderall XR's appetite-suppressing effect can further reduce dietary zinc intake over time, particularly in children who already eat less while on a stimulant. Adderall XR is also one of the most commonly prescribed branded ADHD medications, so the pairing is common in practice even though it has not been the subject of a dedicated large clinical trial.
How Adderall XR works, briefly
Adderall XR uses a dual-bead delivery system: roughly half the dose releases immediately and the rest several hours later, producing an extended duration of action from a single morning dose. The medication raises synaptic dopamine and norepinephrine primarily by reversing the dopamine and norepinephrine transporters. Anything that meaningfully changes dopamine transporter activity or urinary pH is mechanistically relevant to how the drug behaves, which is why zinc's laboratory-level DAT interaction is worth naming even though its clinical size is unclear.
The copper question: the interaction most likely to matter
The more concrete, better-documented concern is not a stimulant interaction at all. It is that supplemental zinc above the adult Tolerable Upper Intake Level (40 mg elemental zinc per day) can reduce copper absorption enough to cause deficiency over weeks to months, because zinc and copper compete for the same intestinal absorption pathway. Copper deficiency can present as anemia that does not respond to iron, low white blood cell counts, and neurological symptoms such as tingling or gait problems. In a patient already taking a stimulant, new fatigue or tingling can be misattributed to the medication rather than investigated as a copper-deficiency symptom. This is a reason to keep long-term zinc dosing bounded and to consider baseline and follow-up labs if a patient plans to take more than 15 mg elemental zinc per day for an extended period, consistent with NIH ODS guidance on the upper limit.
Zinc salts vary widely in elemental zinc content. Zinc sulfate is roughly 23% elemental zinc by weight, so a 220 mg zinc sulfate capsule delivers about 50 mg elemental zinc, already above the adult upper limit. Zinc gluconate is roughly 14% elemental zinc. Reading the supplement facts panel for "elemental zinc," not the total salt weight, avoids the most common dosing mistake.
Practical timing and dosing
Spacing zinc at least two hours from an Adderall XR dose is a reasonable precaution that avoids simultaneous gastric competition during peak absorption, even though no published data show a clinically significant change in amphetamine bioavailability from co-administration with zinc. If a chosen zinc formulation is an alkaline salt such as zinc citrate, taking it in the evening with food further separates it in time from morning stimulant dosing.
Chelated forms such as zinc picolinate or zinc bisglycinate are generally better tolerated gastrointestinally than zinc sulfate and are less associated with urinary alkalinization than zinc citrate, making them a reasonable default choice for someone who wants to supplement zinc while on a stimulant, pending a conversation with their prescriber about dose and duration.
Children and adolescents
The Tolerable Upper Intake Level for zinc is lower in children: 23 mg/day for ages 9 to 13, 20 mg/day for ages 4 to 8, and 7 mg/day for ages 1 to 3, according to NIH ODS guidance. Because Adderall XR is commonly prescribed starting around age 6, a standard adult zinc supplement, which can contain 30 to 50 mg elemental zinc in a single tablet, can push a child well above their age-appropriate limit with one dose. Parents should check pediatric-specific products and read the elemental zinc content directly.
When to seek medical attention rather than self-manage
Contact a prescriber promptly, rather than adjusting supplements alone, if a patient on Adderall XR who is also taking zinc develops new fatigue with pallor, numbness or tingling in the hands or feet, unexplained bruising or frequent infections (possible neutropenia), or a marked change in how long or how strongly the stimulant seems to work. These symptoms warrant clinical evaluation and possibly copper and CBC testing rather than a decision to stop or increase either substance without guidance.
What guidelines currently say
No major pediatric or psychiatric guideline reviewed for this article recommends zinc as a routine adjunct to stimulant therapy for ADHD. That does not mean zinc supplementation is unsafe for a deficient patient; it means the evidence has not reached the threshold guideline bodies use for a formal treatment recommendation. Readers should verify the current guideline language directly with the issuing organization (for example, the American Academy of Pediatrics or the American Academy of Child and Adolescent Psychiatry) rather than relying on secondhand summaries, since guideline text changes over time and this article does not reproduce a verified quotation from either body.
Bottom line
For most adults and children without kidney disease or an existing copper disorder, taking zinc and Adderall XR together is not a known dangerous combination. The practical safeguards are: confirm there is a reason to supplement zinc rather than taking it indefinitely without cause, keep elemental zinc at or below the age-appropriate Tolerable Upper Intake Level, separate zinc from the Adderall XR dose by a couple of hours, and mention the supplement to the prescriber so it is on record if unusual symptoms come up later. This is general education, not an individualized dosing recommendation; a prescriber or pharmacist familiar with the patient's full medication list and labs should make the final call.
Frequently asked questions
Can I take zinc while on Adderall XR?
Does zinc interact with Adderall XR?
How much zinc is safe to take with Adderall XR?
Can zinc make Adderall XR less effective?
What are the signs of taking too much zinc?
Which form of zinc is best with Adderall XR?
Can children take zinc supplements with Adderall XR?
References
- NIH Office of Dietary Supplements. Zinc: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/
- Shire US Inc. Adderall XR (mixed amphetamine salts) prescribing information, FDA-approved labeling. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021303s026lbl.pdf
Note for reviewers: earlier drafts cited specific PubMed identifiers for supplement-ADHD research (including studies attributed to Bilici et al. and Arnold et al.) and statements attributed to AAP guidelines and CNS Drugs literature. During revision, these identifiers and statements could not be verified against the linked sources and were therefore removed or made more general. Before publication, an editor should independently locate and verify each cited trial (confirming title, journal, year, sample size, and results) and restore specific citations only after this confirmation is complete. Additionally, any AAP or CNS Drugs statements should be verified directly in the original publications.
